Name: ABY-035/AFO2
Indication: Psoriasis

• Affibody
• IL-17A inhibitor

Name: M1095/ALX-0761
Indication: Psoriasis

• Merck
• IL-17A and IL-17F inhibitor

Name: Namilumab (MT203)
Indication: Psoriasis

• Takeda
• Granulocyte macrophage colony stimulating factor antagonist

Name: SHR-1314
Indication: Psoriasis

• Jiangsu HengRui Medicine Co., Ltd.
• IL-17A Antagonist

Name: Tildrakizumab (MK-3222/SCH 900222/SUNPG1623)
Indication: PsA

• Merck and Sun Pharma
• IL-23 inhibitor
• Approved to treat psoriasis

Name: Apo805K1
Indication: Psoriasis

• ApoPharma
  

Name: BI 730357
Indication: Psoriasis

• Boehringer Ingelheim
• Nuclear Receptor Antagonist
  

Name: FP187
Indication: Psoriasis

• Forward-Pharma
• Fumaric acid

Name: JTE-451
Indication: Psoriasis

• Akros Pharma Inc.
• RORγ Antagonist
  

Name: KD025 (SLx-2119)
Indication: Psoriasis

• Kadmon Corporation
• ROCK2 inhibitor
  

Name: Orismilast (UNI50001)

Indication: Psoriasis

• UNION Therapeutics
• PDE4-inhibitor

Name: PF-06826647
Indication: Psoriasis

• Pfizer
• TYK2 Inhibitor
  

Name: Prurisol
Indication: Psoriasis

• Cellceutix Corporation
• IL-20 and PRINS inhibitor
  

Name: XP23829
Indication: Psoriasis

• Dr. Reddy’s Laboratories and XenoPort
• Fumaric acid
  

Name: ZPL-389
Indication: Psoriasis

• Ziarco Pharma Ltd.
• Histamine H4 receptor antagonist

Name: Roflumilast (ARQ-154) foam
Indication: Scalp Psoriasis

• Arcutis Biotherapeutics
• PDE4 Enzyme Inhibitor

Name: EISO (SAN021)
Indication: Psoriasis

• Santalis Pharmaceutical, Inc.
• PDE4 blocker
  

Name: Eucrisa (crisaborole/AN2728)
Indication: Psoriasis

• Pfizer
• Phosphodiesterase-4 inhibitor
• Approved for atopic dermatitis
  

Name: LAS41004
Indication: Psoriasis

• Almirall/Aqua
• Bexarotene/betamethasone dipropionate
  

Name: PF-06700841
Indication: Psoriasis and PsA

• Pfizer
• JAK1 and TYK2 inhibitor
  

Name: PH-10
Indication: Psoriasis

• Provectus Biopharmaceuticals
• Rose Bengal
  

Name: SNA-120 (CT 327/pegcantratinib)
Indication: Psoriasis

• Sienna Biopharmaceuticals/Creabilis SA
• TrkA kinase blocker